ClinicalTrials.Veeva

Menu

Efficacy of TaVNS Versus Sham Stimulation in Reduing Depressive Symptoms in Patients with Epilepsy: a Multi-center, Double-blinded, Randomized, 20-week, Parallel-arm, Superiority Study (TIDES)

Zhejiang University logo

Zhejiang University

Status

Active, not recruiting

Conditions

Depressive Symptoms in Patients with Epilepsy

Treatments

Device: Sham Comparator
Device: Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT06794034
2023-0182

Details and patient eligibility

About

The purpose of this study is to compare the efficacy of taVNS versus sham stimulation in reduing depressive symptoms in patients with epilepsy.

Enrollment

158 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults age ≥18
  • Confirmed diagnosis of epilepsy (based on 2014 definition by ILAE)
  • Having comorbidity with mild-moderate depression (confirmed diagnosis by a psychiatrist)
  • Willing and able to provide informed conset

Exclusion criteria

  • Those experiencing status epilepticus or frequent seizures requiring emergency medication within the year prior to recruitment
  • Those with severe depression or anxiety who are in urgent need of psychiatric care
  • Those who are imminently suicidal or unable to keep themselves safe
  • Those experiencing severe cognitive difficulties with day-to-day memory, attention, and ability to learn basic information
  • Those having a pacemaker, a invasive vagus nerve stimulator, or a metal implant
  • The pinna is not suitable for earplugs
  • Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

158 participants in 2 patient groups

"xinlepai","taVNS" 25Hz
Experimental group
Description:
The "xinlepai", a transcutaneous auricular vagus nerve stimulator (taVNS), was used with a stimulation frequency of 25Hz, combined with conventional treatment. Use 3 times daily for 30 minutes each time.
Treatment:
Device: Intervention
"xinlepai","taVNS" 1Hz
Sham Comparator group
Description:
The "xinlepai", a transcutaneous auricular vagus nerve stimulator (taVNS), was used with a stimulation frequency of 1Hz, combined with conventional treatment. Use 3 times daily for 30 minutes each time.
Treatment:
Device: Sham Comparator

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems